Skip to main content
Autobound logo
AbbVie8-K: Acquisition completed

AbbVie completes acquisition of Apogee Therapeutics, Inc.

Read at SEC EDGAR

What happened

The completion of this acquisition triggers significant post-merger integration (PMI) activities.

Source

SEC EDGARSep 3, 2026

Current report (Form 8-K)

AbbVie 8-K

Filing excerpt

On September 3, 2026, AbbVie Inc. (the “Company”) issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc.

sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k...Read the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Form
8-K
Filed
Sep 3, 2026

More from AbbVie

Company page →

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1551152
Accession number
0001104659-26-104940
Timeframe
Immediate
Filing year
2026
Why it matters
Active integration needs
Signal category
Strategic

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
Sep 8, 2026
signal_type
sec-8k
signal_subtype
acquisitionCompleted

Use this data

Get every 8-K signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/3062630e-3d99-45ff-be7e-c4403be260fb returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "3062630e-3d99-45ff-be7e-c4403be260fb",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-09-08T07:04:03.8+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "detail": "The completion of this acquisition triggers significant post-merger integration (PMI) activities. This creates immediate needs for consulting, system integration, and vendor consolidation across IT, finance, and HR departments to align the two organizations.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "AbbVie completes acquisition of Apogee Therapeutics, Inc.",
    "excerpts": "On September 3, 2026, AbbVie Inc. (the “Company”) issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k.htm",
    "filing_date": "2026-09-03",
    "filing_year": 2026,
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.